首页> 美国卫生研究院文献>Environmental Health and Toxicology >Necessity for a National Carcinogen List in Korea Based on International Harmonization
【2h】

Necessity for a National Carcinogen List in Korea Based on International Harmonization

机译:基于国际协调在韩国列入国家致癌物清单的必要性

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

Cancer has been the leading cause of death in Korea for the last 30 years. Cancer patients' 5-year survival rate between 2005 and 2009 was 62.0%, representing a highly advanced standard of care, as much as developed countries in the EU and the US. The Korean government formulated its first 10-year plan for cancer control in 1996 and has been carrying out a second 10-year plan for cancer control since 2006. But despite the Korean government's efforts, the cancer burden in Korea continues to increase. Many separate laws have gone into effect concerning the management of carcinogen exposure. However, there are no integrated regulatory laws or management systems against carcinogen exposure in Korea. Dead zones remain where carcinogen exposure cannot be controlled properly in Korea. In this paper, we suggest the need to establish a national carcinogen list based on international harmonization as a prerequisite for a paradigm shift in cancer control policy from treatment to primary prevention.
机译:在过去的30年中,癌症一直是韩国的主要死亡原因。在2005年至2009年期间,癌症患者的5年生存率是62.0%,与欧盟和美国的发达国家一样,这是高度先进的护理标准。韩国政府于1996年制定了第一个癌症十年计划,自2006年以来一直在执行第二个癌症十年计划。但是,尽管韩国政府做出了努力,韩国的癌症负担仍在继续增加。关于致癌物暴露的管理,许多单独的法律已经生效。但是,韩国没有针对致癌物暴露的综合法规或管理体系。死区仍然存在,致癌物质暴露在韩国无法得到适当控制。在本文中,我们建议有必要建立基于国际统一的国家致癌物清单,这是癌症控制政策从治疗向初级预防转变的前提。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号